Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 999
Localized Leiomyosarcoma Biomarker Protocol
for
Leiomyosarcoma
Location: Rochester MN, Ann Arbor MI, Nashville TN
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 0+
Code: NCT04925089
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Location: Rochester MN, Columbus OH, Atlanta GA, Hershey PA,
Sponsor: Philogen S.p.A.
Sex: All
Age: 18+
Code: NCT03567889
Phase 3, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
for
Myeloid Malignancy, Inherited Bone Marrow Failure Syndrome,
Location: Rochester MN, Jacksonville FL, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT02958462
Recruiting
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
for
Tetralogy of Fallot, Congenital Heart Disease
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05122962
Recruiting
CEUS for Blunt Abdominal Trauma in Children
for
Trauma Abdomen
Location: Rochester MN, Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 17
Code: NCT03490929
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
for
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early,
Location: Rochester MN, Ann Arbor MI, Cleveland OH, Richmond VA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT05832229
Phase 2, Recruiting
Effect of Vagal Nerve Stimulation on Gastric Motor Functions
for
Depression, Epilepsy
Location: Rochester MN, Minneapolis MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06038929
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer